# Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome

> **NCT01945892** · — · COMPLETED · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 23 (actual)

## Conditions studied

- Macular Edema
- Visual Acuity

## Interventions

- **DRUG:** Ozurdex

## Key facts

- **NCT ID:** NCT01945892
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-06
- **Final completion:** 2013-07
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2013-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01945892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01945892, "Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01945892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*